- Home
- ATNM vs AIRT Comparison
ATNM vs AIRT Comparison
Compare ATNM & AIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- AIRT
- Stock Information
- Founded
- ATNM 2000
- AIRT 1980
- Country
- ATNM United States
- AIRT United States
- Employees
- ATNM N/A
- AIRT N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- AIRT Air Freight/Delivery Services
- Sector
- ATNM Health Care
- AIRT Consumer Discretionary
- Exchange
- ATNM Nasdaq
- AIRT Nasdaq
- Market Cap
- ATNM 50.2M
- AIRT 59.6M
- IPO Year
- ATNM N/A
- AIRT N/A
- Fundamental
- Price
- ATNM $1.61
- AIRT $24.46
- Analyst Decision
- ATNM Strong Buy
- AIRT
- Analyst Count
- ATNM 2
- AIRT 0
- Target Price
- ATNM $4.50
- AIRT N/A
- AVG Volume (30 Days)
- ATNM 122.2K
- AIRT 1.2K
- Earning Date
- ATNM 11-13-2025
- AIRT 11-11-2025
- Dividend Yield
- ATNM N/A
- AIRT N/A
- EPS Growth
- ATNM N/A
- AIRT N/A
- EPS
- ATNM N/A
- AIRT N/A
- Revenue
- ATNM N/A
- AIRT $296,309,000.00
- Revenue This Year
- ATNM N/A
- AIRT N/A
- Revenue Next Year
- ATNM N/A
- AIRT N/A
- P/E Ratio
- ATNM N/A
- AIRT N/A
- Revenue Growth
- ATNM N/A
- AIRT 5.14
- 52 Week Low
- ATNM $1.03
- AIRT $14.56
- 52 Week High
- ATNM $2.41
- AIRT $26.70
- Technical
- Relative Strength Index (RSI)
- ATNM 45.72
- AIRT 55.22
- Support Level
- ATNM $1.60
- AIRT $22.63
- Resistance Level
- ATNM $1.70
- AIRT $26.37
- Average True Range (ATR)
- ATNM 0.07
- AIRT 0.33
- MACD
- ATNM -0.01
- AIRT 0.12
- Stochastic Oscillator
- ATNM 32.14
- AIRT 53.53
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.